CompletedNot Applicable

The Effect of Transcutaneous Posterior Tibial Nerve Stimulation in Patients With Fibromyalgia

Turkey (Türkiye)64 participantsStarted 2020-11-02

Plain-language summary

This study aimed to investigate the effectiveness of posterior tibial nerve stimulation (PTNS) in reducing pain, improving quality of life, and decreasing disease severity in patients with fibromyalgia.

Who can participate

Age range18 Years – 65 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female patients aged between 18 and 65 years, newly diagnosed according to the American Rheumatology Association 2016 revised FMS diagnostic criteria * Patients who come regularly to sessions for posterior tibial nerve stimulation. Exclusion Criteria: * History of fracture/musculoskeletal surgery in the last 3 years * Inflammatory joint disease, or neurological disease/neurological deficit with examination * Receiving medical treatment for polyneuropathy * Contraindications to PNS (pacemaker, epilepsy, diminished skin sensation in the area to be applied).

What they're measuring

Change from baseline in Numeric Rating Scale (NRS) of pain score at week 4 and 12

Timeframe: At baseline, 4th week and 12th week

Change from baseline in Short-Form McGill Pain Questionnaire at week 4 and 12

Timeframe: At baseline, 4th week and 12th week

Trial details

NCT IDNCT05937711

SponsorIlker Fatih Sari

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-05-23

View on ClinicalTrials.gov More Fibromyalgia trials